Please login to the form below
Ledaga
This page shows the latest Ledaga news and features for those working in and with pharma, biotech and healthcare.
EU nod for Actelion's skin cancer drug Ledaga
Still need to meet CHMP post-approval requirements. Actelion has won EU approval for Ledaga, a drug to treat a rare form of lymphoma that manifests itself in the skin, but ... The Swiss biotech - which already sells Ledaga (mechlorethamine or chlormethine
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Medical Editor
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- New study identifies drugs that are safe to use in COVID-19 treatment
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- UK pharmacies to begin administering COVID-19 vaccinations
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- PHE study finds people who have had COVID-19 can still transmit the virus
- J&J trims the size of its phase 3 COVID-19 vaccine trial
- Research Partnership appoints Hannah Osborn to MedTech director role
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- NHS is set to begin offering COVID-19 vaccinations to over-70s this week
- Cambridge University develops DNA test for secondary infections in COVID-19 patients
- 2020 - a year to remember or forget?
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Quick links
Infographics
